Sedana Medical AB: Sedana Medical reports first patient treated in Early Access Program in the U.S.

Sedana Medical AB (publ) today reports that the first patient has been treated in the company's Early Access Program (EAP) in the U.S. The program is approved by the U.S. Food and Drug Administration ...
GEN

Moleculent’s Early Access Program Tests Its Cell-Cell Mapping Tech on Immuno-Oncology

When asked what Moleculent’s cell-cell interaction mapping technology provides to translational researchers, CEO Olle Ericsson explained that it adds “a new layer of information,” specifically ...
Business Wire

MaaT Pharma To Present Updated Data for MaaT013 in Early Access Program at the European Hematology Association (EHA) Annual Congress

LYON, France--(BUSINESS WIRE)--Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therapies ...
Seeking Alpha

Nautilus projects 15%-20% expense growth in 2026 as early access program ramps up

Sujal Patel, Co-Founder and CEO, highlighted the public unveiling of the Nautilus Voyager instrument at the US Human Proteome Organization Conference, calling it a "key highlight" and noting, "The ...